Skip to Main Content

Paper Details

Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma.
Oncotarget
24
2017
MB, Medulloblastomas, PLK4, PLK4i, RT, RT and MB cells, RT cells, Rhabdoid tumors, cancer, cancer cells, centriole, embryonal tumors, infants, malignant CNS tumors, malignant brain tumors, orthotropic xenograft model, patients, pediatric medulloblastoma, polo-like kinase 4, rhabdoid tumors
Author NameAffiliation
Rintaro HashizumeNorthwestern University, Feinberg School of Medicine
Daniel Martin WattersonNorthwestern University, Feinberg School of Medicine
Tadanori TomitaAnn and Robert H. Lurie Children's Hospital of Chicago
Tadanori TomitaNorthwestern University, Feinberg School of Medicine
  • 1 - 4

Datasets

Release 1.2